256 filings
Page 8 of 13
8-K
5c7 jeg9ndtj1v1qyc9i
27 Mar 18
Departure of Directors or Certain Officers
12:00am
S-8
308bp
7 Feb 18
Registration of securities for employees
12:00am
8-K
ybqb o69awvvdw
8 Jan 18
Other Events
12:00am
8-K
96ev59mupfqclczo
14 Dec 17
Matinas BioPharma Appoints Matthew A. Wikler, M.D., M.B.A., F.I.D.S.A., to Board of Directors
12:00am
8-K
cxdmrgwt
26 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
960bhexfh9m2 hj
10 Aug 17
Regulation FD Disclosure
12:00am
8-K
32mho ad7a
8 Aug 17
Matinas BioPharma Reports 2017 Second Quarter Financial Results and Reaffirms Clinical and Regulatory Strategy to Advance MAT2203 and MAT2501
12:00am
8-K/A
tnnhabimo6hxz
26 Jun 17
Regulation FD Disclosure
12:00am
8-K
z6vue5 0waikds6bd6
26 Jun 17
Matinas BioPharma Reports Topline Data from Phase 2 Clinical Study of Orally-Administered MAT2203 for the Treatment of Vulvovaginal Candidiasis
12:00am
8-K
b9cq5yjd3
5 Jun 17
Regulation FD Disclosure
12:00am
8-K
rr8kp3 r5
28 Apr 17
Entry into a Material Definitive Agreement
12:00am
424B5
1obs2epzbv n83wv
28 Apr 17
Prospectus supplement for primary offering
12:00am
8-K
gtfub4 psr
18 Apr 17
Matinas BioPharma Appoints Dominick DiPaolo as Senior Vice President of Quality and Regulatory Compliance
12:00am
EFFECT
qzzef3lwrrpda1dzm1yt
12 Apr 17
Notice of effectiveness
12:00am